Biosis Healing produced 6 SCI high-scoring articles in 1 year, with a total impact factor of 62.055

by

Biosis Healing produced 6 SCI high-scoring articles in 1 year, with a total impact factor of 62.055

In 1 year, 6 SCI high-scoring articles have a total impact factor of 62.055, and the average impact factor of a single article has reached 10.343. Putting these numbers together, it's pretty extraordinary.

On December 24th, the latest research results of Biosis Healing SIS hydrogels were released in "Materials Today Bio", the top international journal in the field of materials. In 2021, the scientific research output ended with the result of "6 papers, with a total impact factor of 62.055".

图片1.jpg

Pictured: Statistics of 6 SCI core journals published by Biosis Healing in 2021

As a biomedical enterprise still in the start-up stage, from the first day of establishment of the company in 2012, it has insisted on "R&D and innovation" as the foundation of enterprise development, and is determined to "escort life and health through the transformation of scientific research results". In the past 9 years, the original intention has never changed!

图片2.jpg

Picture: The research results of Biosis Healing SIS materials are included in the authoritative SCI core journal "Advanced Functional Materials", with an impact factor of 18.8

1. Adhere to the people-oriented talent concept of innovation and R&D, and firmly believe that talents are the source of enterprise development: the company has spared no effort to attach importance to the construction of R&D teams, and has successively established "post-doctoral research workstations" and "Biosis Healing Science and Technology Association" to create "first-class talents, first-class platform, first-class products and technologies" as the development direction of the company, and adhere to the virtuous circle development concept of "continue to improve the company's technological innovation capabilities, create industry-leading technologies and products, improve the company's industry competitiveness, and attract more high-tech talents to join".

Young backbones of surgery, materials science, molecular biology, clinical medicine and other disciplines have been introduced successively. R&D personnel account for nearly half of the company, most of whom have master's degrees or above, and a total of 7 postdoctoral fellows are working in the station. Formed a complete departmental layout of basic research, technology development, clinical registration, system quality, intellectual property rights, etc., and can independently implement new product laboratory research and development, preclinical research, clinical research, registration, system certification, pilot production conversion and other comprehensive development work of biomaterials and medical devices.


图片3.jpg

Picture: The research results of Biosis Healing in the field of SIS materials are included in the authoritative SCI core journal "Advanced Healthcare Materials", with an impact factor of 9.933

2. Sufficient investment in R&D funds to encourage scientific researchers to set up projects in Biosis Healing: The senior leaders of Biosis Healing encourage scientific researchers to carry out major projects, scientific and technological cooperation and international exchanges, and provide sufficient research and development funds. It is hoped that all researchers can apply what they have learned and transform their knowledge reserves into scientific and technological achievements.

Since its establishment, the post-doctoral workstation and the Biosis Healing Science and Technology Association have achieved remarkable results. Breakthrough progress has been made in the world's cutting-edge research in absorbable medical tissue adhesive product development, SIS biomaterials product development in the field of oral and skin repair, as well as the world's first SIS biomaterial to promote cell proliferation molecular mechanism research.

图片4.jpg

Picture: The research results of Biosis Healing in the field of SIS materials are included in the authoritative SCI core journal "Composites Part B", with an impact factor of 9.229

3. Focusing on SIS materials, the research results have reached and surpassed the international leading level: Biosis Healing's SIS biomaterials with independent intellectual property rights are treasure research objects in the field of materials, derived from the submucosa of animal small intestine tissue, can be completely degraded and absorbed after implantation in the body, and is resistant to infection and anti-adhesion. The material is a platform material, which can be applied to the repair of almost all soft tissues in the body. It is the most ideal surgical repair material at present and even in the future, and can be studied in a wide range.

Focusing on SIS graft and SIS hydrogels, Biosis Healing's scientific researchers concentrate on studies, and the research results have been favored by the international authoritative SCI core journals for many times. In recent years, the research results of Biosis Healing in the field of SIS have reached and surpassed the international leading level.

At present, based on the SIS material platform, Biosis Healing has laid out more than 10 product matrices, many of which are first launched in China, and many products have been included in the national key research and development plan. SIS biological hernia graft, dura repair mesh, and anal fistula plug have all been listed and won the bids in many provinces and cities across the country. Products such as Staple Line Reinforcement and Oral Repair Graft are about to be certified, and many other products have entered the clinical stage.

图片5.jpg

Picture: The research results of Biosis Healing have been included in the authoritative SCI core journal "Acta Biomaterialia", with an impact factor of 8.947

4. Adhere to the combination of "industry, university, research, medicine, engineering", and explore potential applications based on the pain points of clinical needs: Biosis Healing adheres to the combination of "industry, university, research, medicine, engineering", and cooperates with Tianjin Medical University School of Stomatology, University of California, Los Angeles (UCLA), Institute of Process Engineering, Chinese Academy of Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital Plastic Surgery Hospital and many other institutes and universities have carried out joint research.

In addition, Biosis Healing has carried out clinical cooperation with hundreds of hospitals across the country, and invested 9 million yuan to jointly launch the "Wu Jieping Medical Foundation- Biosis Healing Excellent Surgery Special Fund" with the Wu Jieping Medical Foundation to support clinicians to conduct scientific research and academic research. The pain points and difficulties of clinical needs, explore the potential application of SIS materials in the clinic.

In addition to clinical-related research, Biosis Healing also focuses on the development of disruptive technological innovations in the entire technology industry. In 2021, Biosis Healing donated 1 million yuan to the "Beijing Disruptive Technology Innovation Fund" jointly established by the Ministry of Science and Technology and Beijing, to support technologies that have disruptive and fundamental substitution effects on existing traditional or mainstream technologies, and help The state seizes important breakthroughs in scientific and technological competition and the commanding heights of future development, and grasps the opportunities for technological innovation to promote economic development.

图片6.jpg

Picture: The research results of Biosis Healing are included in the authoritative SCI core journal "Nanoscale", with an impact factor of 7.790

5. Focus on research hotspots in the field of global materials, and lay out new tracks: Biosis Healing's scientific research team focuses on research hotspots in the field of global materials. In addition to SIS biomaterials, it began to deploy in the field of global hot materials in 2017, and established a number of product pipelines. The animal experiment phase has been completed to reserve cutting-edge technology for subsequent development.

图片7.jpg

Picture: The research results of Biosis Healing SIS hydrogel are included in the authoritative SCI core journal "Materials Today Bio", with an impact factor of 7.348

6. Rooted in clinical practice, to be the largest comprehensive solution provider for clinical surgery in China: Up to now, focusing on the field of clinical surgery, Biosis Healing has deployed more than 10 products on the SIS biomaterial platform and nearly 20 products on the minimally invasive surgical instrument platform, plus products in the field of research materials. Biosis Healing's huge array of surgical clinical solutions is amazing enough.

图片8.png

Picture: Zhao Bo, chairman of Biosis Healing, and the leader of its scientific research team

But in this regard, Zhao Bo, the chairman of Biosis Healing, and his scientific research team are not satisfied. There are many things that Biosis Healing can do and want to do around clinical practice. Our goal is to be the largest provider of comprehensive clinical surgical solutions in China. The transformation of scientific research results to escort life. Looking to the future, Biosis Healing will continue to walk on the road of fulfilling its mission.

Friendship Links:

百度一下   |   京东   |  

版权所有®2019BIOSISHEALING